Fluconazole Pediatric Dose — Antifungal Treatment
Fluconazole is a triazole antifungal agent that inhibits fungal cytochrome P450–dependent lanosterol 14α-demethylase, disrupting ergosterol synthesis and cell membrane integrity. It is widely used in pediatric patients for the treatment and prophylaxis of Candida infections, including oropharyngeal candidiasis, esophageal candidiasis, and invasive candidiasis. Both intravenous and oral formulations offer excellent bioavailability, making it a versatile option across inpatient and outpatient settings.
Pediatric Dosing
The recommended fluconazole pediatric dose is 3–12 mg/kg IV or PO every 24 hours. The specific dose selected within this range is guided by the type and severity of infection:
- Oropharyngeal candidiasis: 3 mg/kg/dose every 24 hours
- Esophageal candidiasis: 6 mg/kg/dose every 24 hours
- Invasive/systemic candidiasis: 12 mg/kg/dose every 24 hours
The adult equivalent dose is 200–800 mg/day. Consult institutional protocol for maximum single-dose guidance in pediatric patients.
Worked example: For a 20 kg child with invasive candidiasis: 20 kg × 12 mg/kg = 400 mg per dose every 24 hours.
Indications and Clinical Context
Fluconazole is indicated for the treatment of superficial and invasive fungal infections caused predominantly by Candida species. In the PICU and neonatal settings, it is commonly employed for invasive candidiasis, candidemia, and antifungal prophylaxis in high-risk immunocompromised patients. Higher doses within the 3–12 mg/kg range are reserved for invasive or deep-seated infections where greater tissue penetration and fungicidal activity are required.
Fluconazole demonstrates excellent CNS penetration, supporting its use in Candida meningitis at higher dosing. Dose selection should consider the infecting species, as Candida krusei is intrinsically resistant and some Candida glabrata isolates demonstrate reduced susceptibility; in such cases, alternative antifungal therapy should be considered per institutional and IDSA guidelines.
Administration and Monitoring
Fluconazole may be administered intravenously or orally. IV doses should be infused over 1–2 hours; do not administer as an IV bolus. Oral bioavailability exceeds 90%, allowing straightforward IV-to-PO conversion when the patient can tolerate enteral medications. Once-daily dosing supports adherence in both inpatient and outpatient settings.
- Route: IV infusion or oral (tablet/suspension)
- Frequency: Every 24 hours
- Renal adjustment: Dose reduction required in significant renal impairment; consult institutional protocol
- Drug interactions: Fluconazole is a potent CYP2C9 and moderate CYP3A4 inhibitor — review concomitant medications carefully
- Monitoring: Liver function tests with prolonged use; QTc interval if co-administered with QT-prolonging agents
- Adverse effects: Hepatotoxicity, rash, nausea, and QTc prolongation are the most clinically relevant concerns
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.